Protagonist Therapeutics PTGX
NASDAQ PTGX
$145.82 -2.98 (-2.00%)
As of: Sep 4, 2026 · 12:50 PM EDT

Protagonist Therapeutics (PTGX) EPS (Diluted) (2020 - 2026)

Analysis

Protagonist Therapeutics (PTGX) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 12.23
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 7.15
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.05 Bn 44.05 Bn - -3.06
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.52 Bn 27.68 Bn - 0.15
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -0.06
10 Protagonist Therapeutics 9.61 Bn 9.61 Bn - 2.29
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.29
Mar 31, 2026 0.05
Dec 31, 2025 -0.26
Sep 30, 2025 -0.62
Jun 30, 2025 -0.55
Mar 31, 2025 -0.19
Dec 31, 2024 1.19
Sep 30, 2024 -0.54
Jun 30, 2024 -0.50
Mar 31, 2024 3.26
Dec 31, 2023 0.77
Sep 30, 2023 -0.58
Jun 30, 2023 -0.68
Mar 31, 2023 -0.67
Dec 31, 2022 -0.70
Sep 30, 2022 -0.63
Jun 30, 2022 -0.84
Mar 31, 2022 -0.43
Dec 31, 2021 -0.80
Sep 30, 2021 -0.70